Abstract

Background:Uterine papillary serous adenocarcinoma (UPSAC) occurs 10-fold less frequently than endometrial carcinoma, and is referred to type 2 endometrial adenocarcinoma. The prognosis of UPSAC is worse than that of type I endometrial carcinoma. Herein we report what is only the second case of UPSAC, but it should prove to be more informative than the first reported case.Case Description:A 71-year-old female had three different metastases in the brain; two of the metastases were located in the posterior fossa within the cerebellar parenchyma with perilesional edema, but no mass effect, and the third metastasis was located in the right frontal lobe, and caused hemispheric edema and subfalcine herniation. The lesion that caused mass effect was completely extirpated without any surgical complications. The patient's recovery was excellent. She is able to walk independently, and use her left hand and left arm. Her Karnofsky performance score 5 months postsurgery was 80/100.Conclusion:Based on the outcome in the presented case, we think that in any UPSAC patient with a metastatic brain tumor causing mass effect the symptomatic metastatic tumor must be removed, regardless of disease grade, to ensure optimal quality of life.

Highlights

  • Uterine papillary serous adenocarcinoma (UPSAC) occurs 10‐fold less frequently than endometrial carcinoma, and is referred to type 2 endometrial adenocarcinoma

  • UPSAC accounts for

  • Patients with UPSAC are classified into four groups based on human epidermal growth factor 2 (HER2)

Read more

Summary

Case Report

Multiple brain metastases in a patient with uterine papillary serous adenocarcinoma: Treatment options for this rarely seen metastatic brain tumor. Departments of Neurosurgery, 1Pathology, Baskent University Medical Faculty, Maresal Fevzi Cakmak Cad. 10. Sokak No: 45 C 06490, Bahcelievler, Ankara,Turkey. This article may be cited as: Gulsen S,Terzi A. Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/111/117176

Access this article online
Findings
CASE REPORT
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.